These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 411694)

  • 61. Tissue disposition and excretion of gold and 14C in rats treated with sodium aurothio[1,4-14C]malate or thio [1,4-14C] malic acid.
    Taylor A; King LJ; Marks V
    Xenobiotica; 1985 Mar; 15(3):221-6. PubMed ID: 3927598
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of cyanide on the uptake of gold by red blood cells.
    Graham GG; Haavisto TM; Jones HM; Champion GD
    Biochem Pharmacol; 1984 Apr; 33(8):1257-62. PubMed ID: 6424684
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of aurothiomalate treatment on canine osteosarcoma in a murine xenograft model.
    Scharf VF; Farese JP; Siemann DW; Abbott JR; Kiupel M; Salute ME; Milner RJ
    Anticancer Drugs; 2014 Mar; 25(3):332-9. PubMed ID: 24304691
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability.
    Nieminen R; Vuolteenaho K; Riutta A; Kankaanranta H; van der Kraan PM; Moilanen T; Moilanen E
    Eur J Pharmacol; 2008 Jun; 587(1-3):309-16. PubMed ID: 18448096
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative pharmacology and biological effects of different gold compounds.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1982; 8():54-60. PubMed ID: 6813492
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A study on the inhibition of non-specific neutral proteinase by gold salt. Part 1. Gold sodium thiomalate].
    Arita S
    Nihon Seikeigeka Gakkai Zasshi; 1989 May; 63(5):521-8. PubMed ID: 2571649
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Covalent labelling of histones with aurothiomalate. Gold-labelled H2A-H2B dimers assemble to octamers, which form crystalline helical tubes.
    Greyling HJ; Hapgood JP; Sewell BT; von Holt C
    Eur J Biochem; 1986 Nov; 161(1):133-8. PubMed ID: 3096730
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mouse peritoneal cells exposed to sodium aurothiomalate in vivo.
    Møller-Madsen B; Mogensen SC; Danscher G; Rungby J; Thorlacius-Ussing O; Graudal H
    Int J Tissue React; 1985; 7(6):439-42. PubMed ID: 3936814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Kidney tubular injury in the use of sodium aurothiomalate and its detection by determination of urinary beta-2-microglobulin].
    Ulreich A; Rainer F; Sedlmayr DP; Leb G; Pfeiffer K
    Wien Klin Wochenschr Suppl; 1984; 156():56-7. PubMed ID: 6442061
    [No Abstract]   [Full Text] [Related]  

  • 71. [Toxic effects of the second dose of sodium aurothiomalate in childhood systemic chronic arthritis].
    Bustabad Reyes S; González García T; Trujillo Martín E; Gantes Mora M; Rodríguez-Lozano B
    An Esp Pediatr; 1997 Apr; 46(4):391-3. PubMed ID: 9214235
    [No Abstract]   [Full Text] [Related]  

  • 72. Kinetics of cystine catalysis of the iodine-azide reaction.
    Dahl WE; Pardue HL
    Anal Chem; 1965 Oct; 37(11):1382-6. PubMed ID: 5827769
    [No Abstract]   [Full Text] [Related]  

  • 73. Mechanism of cystine racemization in strong acid.
    Jacobson SJ; Willson CG; Rapoport H
    J Org Chem; 1974 Apr; 39(8):1074-7. PubMed ID: 4847772
    [No Abstract]   [Full Text] [Related]  

  • 74. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.
    Danpure CJ; Fyfe DA; Gumpel JM
    Ann Rheum Dis; 1979 Aug; 38(4):364-70. PubMed ID: 115389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circulating thiomalate after administration of disodium aurothiomalate: impurity or active metabolite?
    Rudge SR; Perrett D; Swannell AJ; Drury PL
    J Rheumatol; 1984 Apr; 11(2):150-2. PubMed ID: 6427462
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sodium aurothiomalate is a mixture.
    Harvey DA; Kean WF; Lock CJ; Singal D
    Lancet; 1983 Feb; 1(8322):470-1. PubMed ID: 6131185
    [No Abstract]   [Full Text] [Related]  

  • 77. The interaction of aurothiomalate and cysteine.
    Danpure CJ
    Biochem Pharmacol; 1976 Nov; 25(21):2343-6. PubMed ID: 11806
    [No Abstract]   [Full Text] [Related]  

  • 78. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 79. Interaction of aurothiomalate and cystine [proceedings].
    Danpure CJ; Lawson KJ
    Biochem Soc Trans; 1977; 5(5):1366-8. PubMed ID: 411694
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.